| Similar Articles |
|---|
 |
Chemistry World
May 28, 2012
Sarah Houlton |
HDL drug class struggling after latest flop The failure of dalcetrapib, a drug from Roche designed to raise HDL, or 'good', cholesterol, has turned the spotlight again on such drugs.   |
Chemistry World
January 19, 2009
Manisha Lalloo |
Synthetic HDL could boost body's 'good cholesterol' US scientists say gold nanoparticle based therapies could be used to help boost levels of good cholesterol in our bodies. |
BusinessWeek
March 11, 2010
Ellen Gibson |
The Quest to Boost Good Cholesterol Cleveland Clinic's Steven Nissen is again pursuing a drug that will attack plaque by raising HDL. |
The Motley Fool
December 4, 2006
Michael P. Cecil |
Pfizer's Cholesterol-Drug Hopes Crumble In surprising and disappointing news, the pharma's promising new drug fails clinical trials. With Pfizer shares declining because of the bad news, is now a good time to buy? |
Chemistry World
January 2007
Derek Lowe |
Opinion: In the Pipeline Here is a look at the recent failure of Pfizer's cholesterol drug, torcetrapib, and what it could mean for the future of pharmaceutical research. |
The Motley Fool
October 5, 2007
Brian Orelli |
Merck's Next Blockbuster? Merck's cholesterol drug comes back from phase 2 testing with no side effects. Investors, take note. |
The Motley Fool
December 1, 2009
Robert Steyer |
Merck Makes a Mark on Good Cholesterol Can't profit from fighting bad lipoproteins? Start boosting the good ones. |
The Motley Fool
December 30, 2003
Arash Mostaghimi |
Turning Cholesterol Into Cash With 62 million Americans suffering from heart disease, it's a huge target for major drug makers. |
Health
January 2008
Jessica Snyder Sachs |
What You Must Know About Your Cholesterol Many of us are in the danger zone, and we don't realize it. What can we start to do right now to change that? |
BusinessWeek
March 11, 2010 |
Four Ways to Raise HDL Four different routes to raising good cholesterol. |
Pharmaceutical Executive
December 1, 2010
Walter Armstrong |
Hyperlipidemia: The Anti-CETPs Redux The crowded cholesterol-control category is the biggest US drug market, with 2010 global sales close to $35 billion, according to IMS Health. |
The Motley Fool
August 24, 2011
Brian Orelli |
Can Roche and Merck Succeed Where Pfizer Failed? CETP inhibitors are lucrative but risky. |
The Motley Fool
November 15, 2011
Brian Orelli |
Good Data, Big Drug Market, but Still Risky Eli Lilly's evacetrapib is behind Roche and Merck. |
HHMI Bulletin
May 2011
Sarah C. P. Williams |
The Next Statin Although clinicians have firmly established the link between cholesterol levels and heart disease, there are still more questions than answers when it comes to the nitty-gritty molecular details of this connection. |
American Family Physician
January 15, 2001 |
Goals for Lowering Your Cholesterol Why is it important to have a normal cholesterol level?... What does the term "total cholesterol" mean?... Why is LDL called the "bad" cholesterol?... What are normal cholesterol levels?... How can I reduce my LDL and total cholesterol levels?... etc. |
American Family Physician
April 15, 2003 |
Cholesterol What is cholesterol?... Why is a high cholesterol level unhealthy?... When should I start having my cholesterol level checked?... Are there different kinds of cholesterol?... What can I do to improve my cholesterol level?... etc. |
The Motley Fool
December 23, 2003
Arash Mostaghimi |
The Cholesterol Wars Who will win the fight to save your arteries? Fortunately for our corpulent country, pharmaceutical companies want to unclog our arteries -- and lighten our wallets. But which pharma stock will add to most girth to a portfolio? |
American Family Physician
March 1, 2002
Richard S. Safeer |
Cholesterol Treatment Guidelines Update In addition to modifying current strategies of risk assessment, the new guidelines stress the importance of an aggressive therapeutic approach in the management of hypercholesterolemia... |
BusinessWeek
December 13, 2004
Kate Murphy |
Cholesterol: The Bigger the Better Many doctors are convinced that getting a more thorough cholesterol test, one that identifies the types of LDL particles, can improve treatment and save lives. |
The Motley Fool
November 16, 2009
Brian Orelli |
Abbott Puts a Nail in Merck's Coffin There's a clear winner from the American Heart Association conference. |
BusinessWeek
April 19, 2004
Catherine Arnst |
Cholesterol: How Low Should It Be? New studies say as low as possible, but drugs aren't for everybody |
The Motley Fool
June 27, 2005
Brian Gorman |
Pfizer's Controversial Pairing The pharmaceutical's strategy of combining an experimental medicine with Lipitor will likely come under increasing fire. Investors, take note. |
AskMen.com
Chris Riddell |
Heart Healthy Foods & Exercises I did a little digging and compiled a list of the top heart-healthy foods and exercises for you to add to your daily routine. |
The Motley Fool
September 24, 2010
Brian Orelli |
Prepare for This $12 Billion Whoosh Pfizer's Lipitor is the top-selling cholesterol drug -- in fact, it's the top selling drug period -- but it'll start to see generic competition in a little over a year. |
American Family Physician
December 15, 2000
Alan J. Garber |
Attenuating Cardiovascular Risk Factors in Patients with Type 2 Diabetes All cardiovascular risk factors except smoking are more prevalent in patients with type 2 diabetes. In addition to exercise, weight control, aspirin therapy and blood pressure control, therapy to modify lipid profiles is usually necessary... |
The Motley Fool
August 23, 2004
Ben McClure |
Rethinking Big Pharma Risk is knocking Big Pharma stocks down. They won't be getting up anytime soon. Competition, soaring R&D costs, shifting business models, and political meddling combine to make drug stocks a riskier place to invest. |
The Motley Fool
August 30, 2007
Brian Orelli |
Merck Tries to Stop the Flushing The FDA will review the pharma's new cholesterol drug. The biggest worry with getting CORDAPTIVE approved is probably not with its effectiveness, but with safety. Investors, take note. |
Nutra Solutions
July 1, 2005 |
Lowered LDL Study finds that subjects with moderately high cholesterol experienced a 6% drop in total cholesterol after taking a 5g daily dose of an immunoglobulin protein isolate over a period of three weeks. |
AskMen.com
February 14, 2002
Sebastien Stefanov |
The Truth About Eggs Eggs have gotten a bad rap over the last few decades. Deemed bad for the heart by health experts, they have been the subjects of criticism and scrutiny. But are our white (sometimes brown) friends really that unhealthy for us? |
American Family Physician
January 15, 2002
Lori J. Mosca |
Optimal Management of Cholesterol Levels and the Prevention of Coronary Heart Disease in Women Elevated levels of low-density lipoprotein cholesterol and triglycerides and low levels of high-density lipoprotein cholesterol are significant risk factors for coronary heart disease. Abundant data show inadequate utilization of lipid-lowering therapy in women... |
Science News
February 24, 2001
Janet Raloff |
Path to heart health is one with a peel Citrus fruits may deserve a more prominent role in the diet. A research team in Canada has just shown that drinking several glasses of orange juice daily can pump up blood concentrations of the so-called good cholesterol... |
BusinessWeek
February 28, 2005
Amy Barrett |
Pfizer Is "At a Fork in the Road" CEO Henry McKinnell discusses the drugmaker's outlook, from new products and advertising to the challenges facing health care. |
The Motley Fool
May 27, 2011
Brian Orelli |
AIM-HIGH? These Drugmakers Better Duck. A government study on cholesterol drugs hurts Abbott and Merck. |
Food Processing
October 2008 |
VitaGranate Activates Heart-healthy Enzyme VitaGranate Pomegranate Extract, a standardized pomegranate extract, was found to be an activator of an important heart-health-influencing enzyme. |
The Motley Fool
December 4, 2006
Michael Leibert |
Whither Pfizer? Bad news follows the upbeat message delivered at Pfizer's R&D briefing. But with strong cash flows, a healthy dividend yield, unparalleled scale, and a discounted share price, Pfizer's risk/reward profile might look attractive to investors. |
Chemistry World
January 14, 2013
Andrew Turley |
Laropiprant recalled Merck & Co has said it is recalling Tredaptive cholesterol tablets in response to trial results that raised safety concerns and the recommendations of a European Medicines Agency safety panel. |
American Family Physician
March 15, 2005
Lockman et al. |
Treatment of Cholesterol Abnormalities The relationship between coronary heart disease and elevated cholesterol levels has been recognized for many years, but now studies show an improvement in patient-oriented outcomes in patients receiving drug therapy. |
AskMen.com
Dustin Driver |
Cholesterol-Reducing Foods Don't despair. Some tasty foods can actually lower your cholesterol levels. |
Science News
July 5, 2003
Janet Raloff |
Soy Greens -- The Coming Health Food? Now, for those who eschew tofu or are tired of crunching soy nuts, Zhen-Yu Chen of the Chinese University of Hong Kong and his colleagues offer a decidedly different soy option: the greens. |
American Family Physician
April 1, 2001
Joan Bedinghaus |
Coronary Artery Disease Prevention: What's Different for Women? Cardiovascular disease is the leading cause of death in women, as well as an important cause of disability, although many women and their physicians underestimate the risk... |
American Family Physician
September 15, 2001
Sarah Morgan & Lori Parry |
Quantum Sufficit High-density lipoprotein (HDL) is living up to its reputation as the "good" cholesterol... Obesity worse for your health than smoking and drinking heavily every day... How well one recovers from a stroke may depend less on medical intervention than on one's outlook and personality... etc. |
American Family Physician
April 15, 2003 |
Coronary Artery Disease: How Your Diet Can Help What is coronary artery disease?... What is cholesterol?... How does lowering LDL cholesterol help?... What foods should I add to my diet?... |
Managed Care
December 2007
Ed Silverman |
Drugs to Plan For in 2008 There are not many traditional medications in the pipeline, and those that are in development probably won't make waves. |
AskMen.com
Shannon Clark |
Cholesterol Lowering Diets If you want a healthy system, it's worth taking the time to understand cholesterol-lowering diets. |
Nutrition Action Healthletter
June 1999 |
Healing Broken Hearts Reversing heart disease with diet and exercise. |
